A citation-based method for searching scientific literature

J Bryan Iorgulescu, Chuxuan Sun, Corey Neff, Gino Cioffi, Catherine Gutierrez, Carol Kruchko, Jennifer Ruhl, Kristin A Waite, Serban Negoita, Jim Hofferkamp, Tarik Tihan, Roger McLendon, Daniel J Brat, Quinn T Ostrom, Jill S Barnholtz-Sloan. Neuro Oncol 2022
Times Cited: 4







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Pieter Wesseling, Daniel J Brat, Ian A Cree, Dominique Figarella-Branger, Cynthia Hawkins, H K Ng, Stefan M Pfister, Guido Reifenberger,[...]. Neuro Oncol 2021
75

MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
50

O6-methylguanine DNA methyltransferase status determined by promoter methylation and immunohistochemistry in gliosarcoma and their clinical implications.
Shin-Hyuk Kang, Kyung-Jae Park, Chae-Yong Kim, Mi Ok Yu, Chul-Kee Park, Sung-Hye Park, Yong-Gu Chung. J Neurooncol 2011
30
25

Gliosarcoma: a clinical and radiological analysis of 48 cases.
Xiaoping Yi, Hang Cao, Haiyun Tang, Guanghui Gong, Zhongliang Hu, Weihua Liao, Lunquan Sun, Bihong T Chen, Xuejun Li. Eur Radiol 2019
17
25

The Misclassification of Diffuse Gliomas: Rates and Outcomes.
J Bryan Iorgulescu, Matthew Torre, Maya Harary, Timothy R Smith, Ayal A Aizer, David A Reardon, Jill S Barnholtz-Sloan, Arie Perry. Clin Cancer Res 2019
23
25

Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
Gary V Walker, Mark R Gilbert, Sujit S Prabhu, Paul D Brown, Mary Frances McAleer. J Neurooncol 2013
33
25

Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
Simone Frandsen, Helle Broholm, Vibeke Andrée Larsen, Kirsten Grunnet, Søren Møller, Hans Skovgaard Poulsen, Signe Regner Michaelsen. Front Oncol 2019
15
25

Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
Daniela Pierscianek, Yahya Ahmadipour, Anna Michel, Laurèl Rauschenbach, Marvin Darkwah Oppong, Cornelius Deuschl, Sied Kebir, Karsten H Wrede, Martin Glas, Martin Stuschke,[...]. Clin Neurol Neurosurg 2021
2
50

Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
E Galanis, J C Buckner, R P Dinapoli, B W Scheithauer, R B Jenkins, C H Wang, J R O'Fallon, G Farr. J Neurosurg 1998
128
25

Treatments of gliosarcoma of the brain: a systematic review and meta-analysis.
Xing Wang, Jiao Jiang, Meixi Liu, Chao You. Acta Neurol Belg 2021
1
100

A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
Geetika Singh, Supriyo Mallick, Vikas Sharma, Nikhil Joshi, Suvendu Purkait, Prerana Jha, Mehar Chand Sharma, Vaishali Suri, Pramod Kumar Julka, Ashok Kumar Mahapatra,[...]. Neuropathology 2012
22
25

The montreal cognitive assessment and mini-mental state examination visuoexecutive subtests in acute ischemic stroke patients and their correlations with demographic and clinical factors.
Wei Wang, Fang-Ming Dong, Kai Shao, Shang-Zun Guo, Zhong-Min Zhao, Yi-Ming Yang, Ya-Xue Song, Jian-Hua Wang. Acta Neurol Belg 2021
1
100

Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis.
Lindsey Lowder, Jennifer Hauenstein, Ashley Woods, Hsiao-Rong Chen, Manali Rupji, Jeanne Kowalski, Jeffrey J Olson, Debra Saxe, Matthew Schniederjan, Stewart Neill,[...]. J Neurooncol 2019
15
25

Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Bertrand Actor, J M J Ludwig Cobbers, Rainer Büschges, Marietta Wolter, Christiane B Knobbe, Peter Lichter, Guido Reifenberger, Ruthild G Weber. Genes Chromosomes Cancer 2002
107
25

Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
Jonathan Frandsen, Andrew Orton, Randy Jensen, Howard Colman, Adam L Cohen, Jonathan Tward, Dennis C Shrieve, Gita Suneja. J Neurosurg 2018
27
25

Gliosarcoma with multiple extracranial metastases: case report and review of the literature.
Thomas L Beaumont, William J Kupsky, Geoffrey R Barger, Andrew E Sloan. J Neurooncol 2007
87
25

The clinical, radiological, and immunohistochemical characteristics and outcomes of primary intracranial gliosarcoma: a retrospective single-centre study.
Yuan Zhang, Jun-Peng Ma, Jian-Cong Weng, Liang Wang, Zhen Wu, Da Li, Jun-Ting Zhang. Neurosurg Rev 2021
2
50

Gliosarcoma: a clinical study.
J Lutterbach, R Guttenberger, A Pagenstecher. Radiother Oncol 2001
90
25

Radiotherapy plus concomitant temozolomide in primary gliosarcoma.
Sebastian Adeberg, Denise Bernhardt, Semi Ben Harrabi, Christian Diehl, Christian Koelsche, Stefan Rieken, Andreas Unterberg, Andreas von Deimling, Juergen Debus. J Neurooncol 2016
20
25

Genetic profile of gliosarcomas.
R M Reis, D Könü-Lebleblicioglu, J M Lopes, P Kleihues, H Ohgaki. Am J Pathol 2000
176
25


Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014.
Katherine Mallin, Amanda Browner, Bryan Palis, Greer Gay, Ryan McCabe, Leticia Nogueira, Robin Yabroff, Lawrence Shulman, Matthew Facktor, David P Winchester,[...]. Ann Surg Oncol 2019
118
25

Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma.
Nayan Lamba, Ugonma N Chukwueke, Timothy R Smith, Keith L Ligon, Ayal Aizer, David A Reardon, J Bryan Iorgulescu. JAMA Oncol 2020
14
25

MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
Michael Weller, Roger Stupp, Guido Reifenberger, Alba A Brandes, Martin J van den Bent, Wolfgang Wick, Monika E Hegi. Nat Rev Neurol 2010
499
25

Clinicopathologic and genomic features of gliosarcomas.
Dakeun Lee, So Young Kang, Yeon-Lim Suh, Ji Yun Jeong, Jung-Il Lee, Do-Hyun Nam. J Neurooncol 2012
39
25

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
25

Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
Deborah R Smith, Cheng-Chia Wu, Heva J Saadatmand, Steven R Isaacson, Simon K Cheng, Michael B Sisti, Jeffrey N Bruce, Sameer A Sheth, Andrew B Lassman, Fabio M Iwamoto,[...]. J Neurooncol 2018
26
25

The somatic genomic landscape of glioblastoma.
Cameron W Brennan, Roel G W Verhaak, Aaron McKenna, Benito Campos, Houtan Noushmehr, Sofie R Salama, Siyuan Zheng, Debyani Chakravarty, J Zachary Sanborn, Samuel H Berman,[...]. Cell 2013
25

Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity.
Seunggu J Han, Isaac Yang, Tarik Tihan, Michael D Prados, Andrew T Parsa. J Neurooncol 2010
84
25

Correlation of MGMT promoter methylation status with gene and protein expression levels in glioblastoma.
Miyuki Uno, Sueli Mieko Oba-Shinjo, Anamaria Aranha Camargo, Ricardo Pereira Moura, Paulo Henrique de Aguiar, Hector Navarro Cabrera, Marcos Begnami, Sérgio Rosemberg, Manoel Jacobsen Teixeira, Suely Kazue Nagahashi Marie. Clinics (Sao Paulo) 2011
65
25

Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome.
Kevin R Kozak, Anand Mahadevan, John S Moody. Neuro Oncol 2009
80
25

Visualizing and interpreting cancer genomics data via the Xena platform.
Mary J Goldman, Brian Craft, Mim Hastie, Kristupas Repečka, Fran McDade, Akhil Kamath, Ayan Banerjee, Yunhai Luo, Dave Rogers, Angela N Brooks,[...]. Nat Biotechnol 2020
969
25

Long noncoding RNA LINC00346 promotes glioma cell migration, invasion and proliferation by up-regulating ROCK1.
Xin Chen, Deheng Li, Lei Chen, Bin Hao, Yang Gao, Liangdong Li, Changshuai Zhou, Xiayun He, Yiqun Cao. J Cell Mol Med 2020
7
25

Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis.
Delong Jiao, Zhenyu Cai, Swati Choksi, Dan Ma, Moran Choe, Hyung-Joon Kwon, Jin Young Baik, Brian G Rowan, Chengyu Liu, Zheng-Gang Liu. Cell Res 2018
70
25

LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer.
Shao-Hua Yu, Jia-Hua Cai, De-Lun Chen, Szu-Han Liao, Yi-Zhen Lin, Yu-Ting Chung, Jeffrey J P Tsai, Charles C N Wang. J Pers Med 2021
6
25


RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
Juan Lin, Snehlata Kumari, Chun Kim, Trieu-My Van, Laurens Wachsmuth, Apostolos Polykratis, Manolis Pasparakis. Nature 2016
210
25

Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
S-Y Jing, Y-Y Lu, J-K Yang, W-Y Deng, Q Zhou, B-H Jiao. Eur Rev Med Pharmacol Sci 2016
55
25

RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.
Wei Wang, Jill M Marinis, Allison M Beal, Shivraj Savadkar, Yue Wu, Mohammed Khan, Pardeep S Taunk, Nan Wu, Wenyu Su, Jingjing Wu,[...]. Cancer Cell 2018
104
25

Necroptosis in development, inflammation and disease.
Ricardo Weinlich, Andrew Oberst, Helen M Beere, Douglas R Green. Nat Rev Mol Cell Biol 2017
466
25

Hydrogen sulfide exposure induces apoptosis and necroptosis through lncRNA3037/miR-15a/BCL2-A20 signaling in broiler trachea.
Xiaojing Li, Menghao Chen, Qunxiang Shi, Hongfu Zhang, Shiwen Xu. Sci Total Environ 2020
38
25

Necroptosis and tumor progression.
Jiong Yan, Peixing Wan, Swati Choksi, Zheng-Gang Liu. Trends Cancer 2022
47
25

COL3A1 and SNAP91: novel glioblastoma markers with diagnostic and prognostic value.
Yuan-Feng Gao, Xiao-Yuan Mao, Tao Zhu, Chen-Xue Mao, Zhi-Xiong Liu, Zhi-Bin Wang, Ling Li, Xi Li, Ji-Ye Yin, Wei Zhang,[...]. Oncotarget 2016
43
25

Upregulated necroptosis-pathway-associated genes are unfavorable prognostic markers in low-grade glioma and glioblastoma multiforme.
Yuanli Dong, Yun Sun, Yangle Huang, Bilikere Dwarakanath, Lin Kong, Jiade Jay Lu. Transl Cancer Res 2019
8
25

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.
Maxim Sorokin, Mikhail Raevskiy, Alja Zottel, Neja Šamec, Marija Skoblar Vidmar, Alenka Matjašič, Andrej Zupan, Jernej Mlakar, Maria Suntsova, Denis V Kuzmin,[...]. Cancers (Basel) 2021
5
25


Glioblastoma and other malignant gliomas: a clinical review.
Antonio Omuro, Lisa M DeAngelis. JAMA 2013
25

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
25

RIPK3 is a novel prognostic marker for lower grade glioma and further enriches IDH mutational status subgrouping.
Guilherme Afonso Vergara, Gisele Cristine Eugenio, Suzana Maria Fleury Malheiros, Elivane da Silva Victor, Ricardo Weinlich. J Neurooncol 2020
12
25

lncCRLA Enhanced Chemoresistance in Lung Adenocarcinoma That Underwent EpithelialMesenchymal Transition.
Weili Min, Liangzhang Sun, Burong Li, Xiao Gao, Shuqun Zhang, Yang Zhao. Oncol Res 2022
8
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.